13
landing page
FasterCures
What We Do
FasterCures, a center of the Milken Institute, is working to build a system that is effe
ctive, efficient, and driven by a clear vision: patient needs above all else.
+ Read More
landing page
FasterCures Advisory Board
landing page
Research Partnership Maturity Model
FasterCures created the Research Partnership Maturity Model (RPMM) toolkit to enable patient organiz
ations that support or conduct research to 1) understand their assets and capab, Access the Model Visualization and Companion Guide
, Tools You Can Use
This collection of tools provides resources aligned to the RPMM domains, and examples that can support the growth of patient organizations hoping to build their capacity in
+ Read More
landing page
About TRAIN
, What is Venture Philanthropy?
Venture philanthropy is a concept very much in vogue but without
a commonly agreed-upon definition.
+ Read More
landing page
Foundation Company Partnership Toolkit
A growing number of foundations are providing funding to biotech and pharma companies to incentivize
research in their disease areas and help start-ups cross the 'Valley of Death'. Use the information in this toolkit
+ Read More
landing page
Foundation University Partnerships Toolkit
Foundations have a long tradition of supporting research conducted by academic institu
ti
+ Read More
landing page
Foundations as Collaboration Conveners Toolkit
Scientific research requires cross-sector, multi-disciplinary collaboration to make progress.
landing page
Case Studies
FasterCures has often found models of medical research innovation outside of the traditional establi
shment, specifically at the nonprofit foundations that comprise The Research Acceleration and Innovation Network (TRAIN)., The Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation (CFF) is recognized as one of the best examples of venture philanthropy in medical re
+ Read More
article
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies
Introduction
Advances in cell and gene therapies are transforming how we treat or potentially cure
disease. Cell and gene therapies aim to address the underlying cause of genetic and acquired diseases.
+ Read More
article
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically
The Honorable Diana DeGette
US House of Representatives
Washington, DC 205
15
The Honorable Fred Upton
US House of Representatives
Washington, DC 20515
+ Read More
article
Collecting and Sharing Patient Data: Guiding Principles, Governance, and Sustainability
Summary
Establishing and developing a data collection and management platform can be a central acti
vity for many patient foundations that have a mission to advance biomedical R&D.
+ Read More
article
Cures for Life Quarterly — May 2021
In this Issue
Regulatory and Drug Development »